Arthur Becker’s New Project Looks Incredible

A walk through Arthur Becker’s real estate office in Tribeca would yield to you some interesting information. Becker is a big name and face in the New York real estate world but his office paints a slightly different picture. One half of his artist is dedicated to all things real estate while the other half is focused on his artwork. The art studio is filled with paintings, sculptures, and works in progress. Becker is a wonderful example of a man with multiple passions who has managed to balance them in his business life.

Right now Arthur Becker’s attention seems primarily focused on his work at 465 Washington Street in New York. His goal for this building is to develop a multi-unit condo that blends his love of art and fashion with his take on what luxury and high end apartments are lacking. The condo development is valued at $53 million and we expect to see the solo project come to fruition sooner than later. For years Becker has been mostly playing the role of real estate investor behind the scenes, seemingly not interested in having his name on the building. Now it appears that the times have changed and Becker wants his work known. We’re eager to see what happens with the building as work continues.

In an article on NY Daily News, in order to get his building going at 465 Washington Street Becker had to make some moves. Back in August Becker had to cut a deal with adjacent townhouses on Sullivan Street in order to complete his building the way he had planned it. These townhouses were acquired in exchange for a stake in the condo after it gets built. This is the kind of dealmaker that has made Becker such a force int he real estate world. Becker has also been the money man behind works from Michael Stern and Kevin Maloney.

Arthur Becker got his start back in the early 2000’s when he struck a goldmine as a stockbroker working with various tech companies. Becker translated that first fortune into his current success in the realm of real estate, largely focusing on New York.

Click here: https://angel.co/arthur-becker-nyc

JeanMarie Guenot and Amphivena Therapeutics

JeanMarie Guenot graduated from Wharton School of business with an MBA. She went on to receive a Ph.D. from the University of California, San Francisco. She is a business executive who has over 20 years of experience in the biotechnology and pharmaceutical industry. JeanMarie Guenot currently is the CEO and President of Amphivena Therapeutics, Inc. Amphivena technologies on guenotllc.com. The company works with developing bifunctional antibody therapies for hematologic disorders. Their work with immunotherapy and leukemia has shown positive results.

The sphere of blood diseases has a high need for development and new technology.

JeanMarie Guenot has worked with companies in all stages of development in the public and the private sector. Before her current role, Guenot worked with SKS Ocular which specialized in ophthalmics. She founded, ran, and built that company.

Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies

Her prior experience in biotechnology and pharmacy includes working with PDL BioPharma, where she was Vice President of Corporate & Business Development. There they developed treatments for Phase 2 cancer and autoimmunology disease drug candidates. In 2005, JeanMarie Guenot received the Innovative Bio-Partnering Award from BioBusiness. Her work in oncology spans years. She began her career as a preclinical scientist at R&D at Hoffmann-La Roche developing medicines for cancer, autoimmune diseases, and inflammation.

Learn more about Jeanmarie Guenot: http://www.businesswire.com/news/home/20170111005414/en/Maverick-Therapeutics-Takeda-Announce-Five-year-Collaboration-Advance

EOS Lip Balm Gets a Lot of Praise

The EOS brand has become one of the most popular brands of lip balm on the market because it has a certain amount of appeal that sets this brand apart from the competition. There are people that are going to embrace this brand because it overshadows so many of the other brands out there. It has become known as the colorful lip balm container that is sweeping the nation.

EOS has a large number of people that are going to embrace this type of lip balm because it just lasts longer. There is a large amount of interest in this long lasting flavor because that is something that lip balm was not known for in the past. EOS lip balm has managed to get a lot of people to consider the benefits of getting this type of lip balm because it contains such great ingredients. It has the safe Shea butter ingredients and that makes a lot of people consider this over the other brands that are currently out there.

EOS is the company that has evolved as one of the hottest brands on Walgreens with the celebrities that are using lip balm. Out in public there are a lot of people that are seen with this, and these pictures have surfaced on social media. It was just a matter of time before the buzz about these products would grow. There are a large number of women that are interested in these products just because they have seen their favorite celebrities with these products. That is the driving factor for a whole lot of women that are using EOS lip balm. The Miley Cyrus fan base, for example, is going to stock up on EOS lip balm simply because they see Miley using it. That is what makes this brand popular with a young generation. Visit the exclusive Evolution of Smooth.com website for more purchasing options and first-time promotional deals.

https://www.luckyvitamin.com/m-2220-eos-evolution-of-smooth

Achieving Better Retirement Through Low Cost Investment

Warren Buffet has used a different investment strategy to yield better returns; wagering USD 1 million for charity, instead of the usual mediocre and costly funds that shortchange investors. Less expensive and simple investments which should be purchased and held for longer periods are more rewarding. The bottom-up investment approach used by Mr. Buffet has been effective for many years.

Americans need to save more for retirement and invest for their future, but passive index returns are not the safest path to better retirement. Most mutual funds offer a mediocre or poor return in the long run due to excessive trading and high management fees. In addition, one cannot predict the risks and opportunity costs of passive index investments. A wise investor is one who uses investment strategies that will enable him to do better than the crowd in bad times, and low costs are the key to good long-term investment returns.

About Timothy Armour
Timothy Armour, based in Los Angeles, is the Chair and CEO of Capital Group in addition to being an equity portfolio manager. He was named Chair of the company in 2015. Timothy is also the chair of the Capital Research and Management Company, Inc as well as the Capital Group Companies Management Committee. Timothy has a Bachelor’s Degree in Economics from Middlebury College.

Timothy has gained his thirty-four years of investment experience at various positions he has served at Capital Group. He joined Capital Group as an Associates Program participant and slowly climbed the ladder in the organization to the position he holds now.

Learn more about Timothy Armour: https://www.youtube.com/watch?v=-a5Pt_qz36Q

Innovative Technology at Cancer Treatment Centers of America

At one time or another, we’ve all thought about that one thing we never want to think about: cancer. It is everyone’s hope and prayer that they or their loved one’s will never receive that devastating news: You have cancer.
Thankfully, for those that do, they can turn to https://www.myctca.com. Here, they will receive personalized care that is above the rest. CTCA realizes that no two patients are the same, which is why everyone receives personalized attention suited to their own needs. A team of expert and experienced doctors is always available to answer any questions, and to ensure that you know what to expect. They will guide you through the treatment process to help you feel as comfortable as possible. With 5 hospitals across the nation, CTCA is sure to have a location that is accessible to anyone. They will also assist with scheduling your travel plans.
Currently, CTCA is partnering with NantHealth and Allscripts to create a Clinical Pathways program which will help the cancer treatment program. This will help to ensure that patients are receiving the latest innovations in cancer treatment. Doctors will now be able to create a list of care protocols at the point of care. The system will be more personalized, creating custom treatment regimens. It will also compare treatment options, creating a more efficient path of treatment for each patient. It will also provide faster responses from insurance companies for payment. The system will be available at all five Cancer Center Treatment of America locations.

For more information follow Cancer Center Treatment of America on Facebook.

Securus Aims To Stop Prisoners From Perpetuating Crime With Innovations

This may come as a shock to you, but convicted criminals are the population most likely to commit crimes. I know. It’s a revelation. But that simple statement has far reaching impact. Just think about it — prisons are a collection of criminals. In a way, we do criminals a favor by housing them together. They are with a bunch of like-minded people. They are able to plan future crimes together, and they can even perpetrate more crime within a prison.

 

Prisons contain a particular type of economy. Contraband is high on the list of desirable and tradeable items. Contraband ranges from alcohol, drugs, weapons and food items. No matter how vigilant law enforcement stays, contraband always seems to enter a prison. And contraband can literally lead to death in some cases.

 

It is paramount that we prevent crimes originating in prisons. These could be crimes that are planned while the criminals are serving their time, or it could be crimes taking place in the prison itself. After all, prison guards need protection, too.

 

That’s why I am so excited to read about Securus. Prisons need telecommunications services. Securus is a telecommunications company that only services prisons and jails. They get these government contracts to take over whole prisons. Every electronic communication into and out of that contracts prison is provided by Securus.

 

The company records everything. They record video chats and phone calls. All of this recorded information piles up into a massive digital database. But how do you search the database for information about crime? Easy, you use Securus’s own software that can search the database for a particular voice.

 

If law enforcement is suspicious about a particular person, they can turn to Securus for every electronic communication that person has ever made. That’s how you get ahead of crime.

 

How EOS Outdid Chapstick

When you think of lip balm you are likely significantly more brand loyal than people were just a decade ago. For long, the lip balm market was ignored by many of the larger players in the industry such a Chapstick and Blistex, both subsidiaries of larger organizations. These entities were not changing around their lip balm formulas to meet changing customer tastes and preferences and few customers were excited or passionate about their lip balm.

For a new competitor to the market this looked like an opportunity, and EOS, an acronym of the Evolution of Smooth, capitalized on this opportunity to gain foothold into a large market. The founds of the company, as detailed in a Fast Company article, were able to use their experience in other large companies like Pepsi a Unilever, to spot a market need and work to meet it.

EOS lip balm did so by understanding that women bought most of the lip balm and were looking for products with more original and tasty flavors other than the largely medicine tasting varieties sold by Chapstick. These customers were also seeking out a lip balm that was had organic and natural ingredients that were of better quality than the petroleum jelly products sold by their competition.

EOS designed a lip balm that met these needs but found it initially challenging to create a lip balm that stood out to customers. To do so they created an applicator orb that was safe and sanitary, but easier to find in a women’s purse, as well as in stores. They then inked distribution agreements with several major retail chains and online merchants such as eBay and Amazon and began to be widely distributed.

The superiority of their product and the better identification with customers began to pay off and EOS saw monumental growth n addition to the market disruption that they caused. Ultimately, EOS was able to exploit a market opportunity by catering to their Facebook fan base and crafting a unique product that allowed them to stand out in the market.

Product Links:

 

Jeanmarie Guenot is Guiding Amphivena Therapeutics in the Fight Against Life-threatening Diseases

 

JeanMarie Guenot got a Ph.D. from the University of California and an advanced degree in business administration from the University of Pennsylvania. Guenot has two decades of work experience in the biotechnology and pharmaceutical industry. She has managed high-profile research institutions and pharmaceutical firms.

 

Guenot’s work experience

 

Guenot began her career in 1993 at Hoffman-La Roche as a scientist. She participated in the development of drugs for various medical conditions such as autoimmune diseases, inflammation, melanomas, and metabolic diseases. In 2000, Guenot joined Atlas Venture as an associate. Her role in this company was to manage capital investments. Three years later, she was appointed VP of PDL BioPharma. Guenot spearheaded activities in the corporate and business development division of the company.

Her role was to oversee mergers & acquisitions, licensing, management of product portfolios, and alliances. In 2008, she launched Guenot, LLC and served as its managing partner. A year later, she co-founded SKS Ocular, LLC. This company pioneered the development of unrelenting release ocular drug conveyance technologies, dry AMD, Ocular inflammation, and therapeutics for glaucoma.

 

Jeanmarie Guenot and Amphivena Therapeutics enters an agreement with Janssen Biotech

 

Amphivena Therapeutics is a biotechnology company established in 2012. This California-headquartered company specializes in the development of immunotherapy technologies for hematologic malignancies. A year after its inception, Amphivena Therapeutics raised about $14 million in its first series of financing with the help of MPM Capital. In 2013, this company made a deal with Janssen Biotech, which gave Janssen the power to acquire Amphivena with the approval of IND.

 

In 2015, Amphivena announced its achievement under its new agreement with Janssen. This company selected a candidate to participate in clinical trials for a new tumor antigen. This success prompted the issuance of funds to Amphivena by Johnson & Johnson Innovation. Amphivena’s candidate was given RECRUIT-TandAb, a drug conjugate with bi-specific molecules that bind on tumor cells and cause cell lysis. RECRUIT-TandAb is showing promising results in the fight against cancer.

According to JeanMarie Guenot, this discovery is a significant milestone for the company and the science fraternity. She also added that Amphivena Therapeutics would continue to conduct more research to address the various forms of life-threatening cancers.  BusinessWire writes more about what Jeanmarie has done, and continues to do in the future through biotechnology.

What Entrepreneurs Can Learn From Adam Goldenberg

Being an entrepreneur is where all of the earning potential lies. However, not everyone can pull it off. It takes a special type of talent to do so. Even people with the talent need someone to learn from in order to make sure that they are successful at what they do. It is important to be organized in order to bring out the desired success on matrixpartners.com. There are a lot of factors that people need to take care of in order to improve their chances of being a successful entrepreneur. One of the worst things one can do is to try to jump in with no knowledge.

Read more: Vator Splash Oakland – What’s it like to be a Unicorn? Adam Goldenberg (CEO, JustFab)

Among the steps that people need to take in order to make sure that they are successful. The first step is to pursue what interests them the most and think about the type of business model that would work best for their passion. They should also figure out how they are going to earn money at http://vator.tv/person/adam-goldenberg. Another thing they can do is make adjustments to their business model and earning methods as they go along in order to maximize their success. It does not hurt to have help when it comes to business.

Adam Goldenberg is one example of someone who has pursued what he loves. He has also paid attention to his changing values. He has decided to take on the fashion industry. However, his area in the fashion industry is in the data and analytical process on Instagram. He looks at the data in order to determine what products to offer people. He looks at what is selling so that he will know what more to stock up on. The items that are not selling as much will not get as much orders.

Adam Goldenberg has also worked with partners such as Kate Hudson and Don Ressler. He has started up TechStyle which is a company that deals with the trends and tries to change the way fashion is brought to people. One thing about fashion is that there are companies that offer clothes at the expense of workplace safety. TechStyle is one company that is setting the example to follow when it comes to workplace safety.

New Jersey dentist Avi Weisfogel develops innovative sleep apnea treatment

Dr. Avi Weisfogel was working as a successful dentist. He had built his practice, Old Bridge Dental, into one of the leading dental offices in Central New Jersey. He worked hard and had developed many lasting relationships with patients, who kept coming back for his effective treatments and positive clinical environment.

Still, Dr. Avi Wiesfogel found time to research ways to improve his practice. One thing that had always nagged at him was the thought that dentists, as trained medical professionals, could be doing more in the way of early detection and treatment of diseases of the head, neck and mouth area. Dr. Weisfogel thought that training himself and his staff in the diagnosis of the most prevalent diseases which were likely to be afflicting his patients was a good way to add value to the patients and contribute to the general state of well-being of his hometown.

In an era before Obamacare, Dr. Weisfogel was aware that medical costs and the cost of insurance often drove patients to put off routine physical checkups and any other interaction with the medical profession for as long as possible. While someone could indefinitely postpone a yearly checkup with their doctor, postponing an appointment with a dentist for a painful cavity or abscessed tooth was impossible. For these reasons, dentists were often the only medical professionals who would see a given patient for years on end.

With this knowledge, Dr. Weisfogel set out to determine which diseases had the most missed diagnoses and, thus, which areas of medicine could most benefit from training dentists to practice in them. After a few years of intense study, Dr. Weisfogel came across sleep apnea.

Sleep apnea is a silent killer that had long been permitted to run rampant. Over 90% of sufferers didn’t even know they had the illness. What more, sleep apnea is strongly associated with everything from heart attack, stroke and diabetes to fatal workplace accidents. Dr. Weisfogel thought he could change that.

In 2010, he founded Dental Sleep Masters, a program that trains dentists to recognize and treat sleep apnea. The program has been a wild success. Dr. Weisfogel is now widely credited as being the father of sleep dentistry and has improved the lives of thousands of patients across the country.

https://www.facebook.com/avi.weisfogel for more.